PHARMACYTE BIOTECH, INC. Research and Development Expense
PHARMACYTE BIOTECH, INC. (PMCB) reported Research and Development Expense of $60.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. research and development expense for the quarter ending 2026-07-31 was $60.00K, a 36.95% decline year-over-year.
- PHARMACYTE BIOTECH, INC. research and development expense for the quarter ending 2026-04-30 was $61.95K, a 51.12% decline year-over-year.
- PHARMACYTE BIOTECH, INC. research and development expense for the quarter ending 2026-01-31 was $93.11K, a 21.22% decline year-over-year.
- PHARMACYTE BIOTECH, INC. research and development expense for the quarter ending 2025-10-31 was $141.09K, a 44.75% increase year-over-year.
- PHARMACYTE BIOTECH, INC. research and development expense for fiscal 2026 was $391.30K, a 10.75% decline from fiscal 2025.
- PHARMACYTE BIOTECH, INC. research and development expense for fiscal 2025 was $438.42K, a 7.60% increase from fiscal 2024.
- PHARMACYTE BIOTECH, INC. research and development expense for fiscal 2024 was $407.43K, a 13.04% decline from fiscal 2023.
- PHARMACYTE BIOTECH, INC. research and development expense for fiscal 2023 was $468.54K, a 32.19% decline from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-07-31 | $60.00K 10-Q · filed 2026-09-14 | $121.95K derived: sum of 2 quarters · filed 2026-09-14 | $215.06K derived: sum of 3 quarters · filed 2026-09-14 | $356.14K derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $61.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $155.06K derived: sum of 2 quarters · filed 2026-07-29 | $296.14K derived: sum of 3 quarters · filed 2026-07-29 | $391.30K 10-K · filed 2026-07-29 |
| 2026-01-31 | $93.11K 10-Q · filed 2026-03-17 | $234.20K derived: sum of 2 quarters · filed 2026-03-17 | $329.36K 10-Q · filed 2026-03-17 | $456.09K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $141.09K 10-Q · filed 2025-12-18 | $236.24K 10-Q · filed 2025-12-18 | $362.98K derived: sum of 3 quarters · filed 2026-09-14 | $481.17K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $95.16K 10-Q · filed 2026-09-14 | $221.89K derived: sum of 2 quarters · filed 2026-09-14 | $340.09K derived: sum of 3 quarters · filed 2026-09-14 | $437.56K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $126.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $244.93K derived: sum of 2 quarters · filed 2026-07-29 | $342.40K derived: sum of 3 quarters · filed 2026-07-29 | $438.42K 10-K · filed 2026-07-29 |
| 2025-01-31 | $118.20K 10-Q · filed 2026-03-17 | $215.67K derived: sum of 2 quarters · filed 2026-03-17 | $311.68K 10-Q · filed 2026-03-17 | $405.87K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | $97.47K 10-Q · filed 2025-12-18 | $193.49K 10-Q · filed 2025-12-18 | $287.67K derived: sum of 3 quarters · filed 2025-12-18 | $414.40K derived: sum of 4 quarters · filed 2025-12-18 |
| 2024-07-31 | $96.02K 10-Q · filed 2025-09-15 | $190.20K derived: sum of 2 quarters · filed 2025-09-15 | $316.93K derived: sum of 3 quarters · filed 2025-09-15 | $398.96K derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | $94.18K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $220.91K derived: sum of 2 quarters · filed 2025-08-11 | $302.95K derived: sum of 3 quarters · filed 2025-08-11 | $407.43K 10-K · filed 2025-08-11 |
| 2024-01-31 | $126.73K 10-Q · filed 2025-03-17 | $208.76K derived: sum of 2 quarters · filed 2025-03-17 | $313.25K 10-Q · filed 2025-03-17 | $399.12K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | $82.03K 10-Q · filed 2024-12-13 | $186.52K 10-Q · filed 2024-12-13 | $272.39K derived: sum of 3 quarters · filed 2024-12-13 | $317.78K derived: sum of 4 quarters · filed 2024-12-13 |
| 2023-07-31 | $104.48K 10-Q · filed 2024-09-17 | $190.36K derived: sum of 2 quarters · filed 2024-09-17 | $235.75K derived: sum of 3 quarters · filed 2024-09-17 | $413.75K derived: sum of 4 quarters · filed 2024-09-17 |
| 2023-04-30 | $85.87K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | $131.27K derived: sum of 2 quarters · filed 2024-08-13 | $309.26K derived: sum of 3 quarters · filed 2024-08-13 | $468.54K 10-K · filed 2024-08-13 |
| 2023-01-31 | $45.39K 10-Q · filed 2024-03-18 | $223.39K derived: sum of 2 quarters · filed 2024-03-18 | $382.66K 10-Q · filed 2024-03-18 | $636.73K derived: sum of 4 quarters · filed 2024-03-18 |
| 2022-10-31 | $178.00K 10-Q · filed 2023-12-15 | $337.27K 10-Q · filed 2023-12-15 | $591.33K derived: sum of 3 quarters · filed 2023-12-15 | $749.37K derived: sum of 4 quarters · filed 2023-12-15 |
| 2022-07-31 | $159.27K 10-Q · filed 2023-09-18 | $413.34K derived: sum of 2 quarters · filed 2023-09-18 | $571.38K derived: sum of 3 quarters · filed 2023-09-18 | $706.60K derived: sum of 4 quarters · filed 2023-09-18 |
| 2022-04-30 | $254.06K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | $412.10K derived: sum of 2 quarters · filed 2023-07-31 | $547.32K derived: sum of 3 quarters · filed 2023-07-31 | $690.94K 10-K · filed 2023-07-31 |
| 2022-01-31 | $158.04K 10-Q · filed 2023-03-16 | $293.26K derived: sum of 2 quarters · filed 2023-03-16 | $436.87K 10-Q · filed 2023-03-16 | $757.14K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | $135.22K 10-Q · filed 2022-12-14 | $278.83K 10-Q · filed 2022-12-14 | $599.11K derived: sum of 3 quarters · filed 2022-12-14 | $773.19K derived: sum of 4 quarters · filed 2022-12-14 |
| 2021-07-31 | $143.61K 10-Q · filed 2022-09-14 | $463.89K derived: sum of 2 quarters · filed 2022-09-14 | $637.97K derived: sum of 3 quarters · filed 2022-09-14 | $789.29K derived: sum of 4 quarters · filed 2022-09-14 |
| 2021-04-30 | $320.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | $494.36K derived: sum of 2 quarters · filed 2022-07-28 | $645.67K derived: sum of 3 quarters · filed 2022-07-28 | $916.25K 10-K · filed 2022-07-28 |
| 2021-01-31 | $174.09K 10-Q · filed 2022-03-15 | $325.40K derived: sum of 2 quarters · filed 2022-03-15 | $595.98K 10-Q · filed 2022-03-15 | $693.63K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $151.31K 10-Q · filed 2021-12-14 | $421.89K 10-Q · filed 2021-12-14 | $519.54K derived: sum of 3 quarters · filed 2021-12-14 | $632.84K derived: sum of 4 quarters · filed 2021-12-14 |
| 2020-07-31 | $270.57K 10-Q · filed 2021-09-14 | $368.23K derived: sum of 2 quarters · filed 2021-09-14 | $481.52K derived: sum of 3 quarters · filed 2021-09-14 | $499.46K derived: sum of 4 quarters · filed 2021-09-14 |
| 2020-04-30 | $97.66K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | $210.95K derived: sum of 2 quarters · filed 2021-08-10 | $228.89K derived: sum of 3 quarters · filed 2021-08-10 | $301.22K 10-K · filed 2021-08-10 |
| 2020-01-31 | $113.30K 10-Q · filed 2021-03-12 | $131.24K derived: sum of 2 quarters · filed 2021-03-12 | $203.57K 10-Q · filed 2021-03-12 | $221.58K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-10-31 | $17.94K 10-Q · filed 2020-12-11 | $90.27K 10-Q · filed 2020-12-11 | $108.28K derived: sum of 3 quarters · filed 2020-12-11 | $167.43K derived: sum of 4 quarters · filed 2020-12-11 |
| 2019-07-31 | $72.33K 10-Q · filed 2020-09-11 | $90.34K derived: sum of 2 quarters · filed 2020-09-11 | $149.49K derived: sum of 3 quarters · filed 2020-09-11 | $264.59K derived: sum of 4 quarters · filed 2020-09-11 |
| 2019-04-30 | $18.01K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $77.16K derived: sum of 2 quarters · filed 2020-08-13 | $192.26K derived: sum of 3 quarters · filed 2020-08-13 | $460.05K 10-K · filed 2020-08-13 |
| 2019-01-31 | $59.14K 10-Q · filed 2020-03-13 | $174.25K derived: sum of 2 quarters · filed 2020-03-13 | $442.04K 10-Q · filed 2020-03-13 | $694.16K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-10-31 | $115.10K 10-Q · filed 2019-12-23 | $382.89K 10-Q · filed 2019-12-23 | $635.01K derived: sum of 3 quarters · filed 2019-12-23 | $1.44M derived: sum of 4 quarters · filed 2019-12-23 |
| 2018-07-31 | $267.79K 10-Q · filed 2019-09-13 | $519.91K derived: sum of 2 quarters · filed 2019-09-13 | $1.32M derived: sum of 3 quarters · filed 2019-09-13 | $1.84M derived: sum of 4 quarters · filed 2019-09-13 |
| 2018-04-30 | $252.12K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $1.05M derived: sum of 2 quarters · filed 2019-08-13 | $1.57M derived: sum of 3 quarters · filed 2019-08-13 | $2.00M 10-K · filed 2019-08-13 |
| 2018-01-31 | $802.56K 10-Q · filed 2019-03-14 | $1.32M derived: sum of 2 quarters · filed 2019-03-14 | $1.75M 10-Q · filed 2019-03-14 | $1.92M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-10-31 | $515.46K 10-Q · filed 2018-12-14 | $943.13K 10-Q · filed 2018-12-14 | $1.12M derived: sum of 3 quarters · filed 2018-12-14 | $1.70M derived: sum of 4 quarters · filed 2018-12-14 |
| 2017-07-31 | $427.67K 10-Q · filed 2018-09-12 | $601.43K derived: sum of 2 quarters · filed 2018-09-12 | $1.18M derived: sum of 3 quarters · filed 2018-09-12 | $1.43M derived: sum of 4 quarters · filed 2018-09-12 |
| 2017-04-30 | $173.76K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | $753.48K derived: sum of 2 quarters · filed 2018-07-20 | $1.01M derived: sum of 3 quarters · filed 2018-07-20 | $1.18M 10-K · filed 2018-07-20 |
| 2017-01-31 | $579.72K 10-Q · filed 2018-03-19 | $833.49K derived: sum of 2 quarters · filed 2018-03-19 | $1.01M 10-Q · filed 2018-03-19 | $1.25M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | $253.77K 10-Q · filed 2017-12-14 | $428.77K 10-Q · filed 2017-12-14 | $666.34K derived: sum of 3 quarters · filed 2017-12-14 | $1.24M derived: sum of 4 quarters · filed 2017-12-14 |
| 2016-07-31 | $175.00K 10-Q · filed 2017-09-13 | $412.58K derived: sum of 2 quarters · filed 2017-09-13 | $986.55K derived: sum of 3 quarters · filed 2017-09-13 | $1.43M derived: sum of 4 quarters · filed 2017-09-13 |
| 2016-04-30 | $237.57K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | $811.55K derived: sum of 2 quarters · filed 2017-07-27 | $1.25M derived: sum of 3 quarters · filed 2017-07-27 | $1.41M 10-K · filed 2017-07-27 |
| 2016-01-31 | $573.98K 10-Q · filed 2017-03-13 | $1.01M derived: sum of 2 quarters · filed 2017-03-13 | $1.17M 10-Q · filed 2017-03-13 | $4.02M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-10-31 | $439.71K 10-Q · filed 2016-12-02 | $595.39K 10-Q · filed 2016-12-02 | $3.45M derived: sum of 3 quarters · filed 2016-12-02 | $3.72M derived: sum of 4 quarters · filed 2016-12-02 |
| 2015-07-31 | $155.68K 10-Q · filed 2016-09-06 | $3.01M derived: sum of 2 quarters · filed 2016-09-06 | $3.28M derived: sum of 3 quarters · filed 2016-09-06 | $3.63M derived: sum of 4 quarters · filed 2016-09-06 |
| 2015-04-30 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $3.13M derived: sum of 2 quarters · filed 2016-07-29 | $3.48M derived: sum of 3 quarters · filed 2016-07-29 | $3.48M 10-K · filed 2016-07-29 |
| 2015-01-31 | $273.80K 10-Q · filed 2016-03-08 | $621.57K derived: sum of 2 quarters · filed 2016-03-08 | $621.57K 10-Q · filed 2016-03-08 | $945.07K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-10-31 | $347.76K 10-Q/A · filed 2016-01-19 | $347.76K 10-Q/A · filed 2016-01-19 | $671.26K derived: sum of 3 quarters · filed 2016-07-29 | $671.26K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-07-31 | $0.00 10-Q/A · filed 2016-01-19 | $323.50K derived: sum of 2 quarters · filed 2016-07-29 | $323.50K derived: sum of 3 quarters · filed 2016-07-29 | $323.50K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-04-30 | $323.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $323.50K derived: sum of 2 quarters · filed 2016-07-29 | $323.50K derived: sum of 3 quarters · filed 2016-07-29 | $323.50K 10-K · filed 2016-07-29 |
| 2014-01-31 | $0.00 10-Q · filed 2015-03-13 | $0.00 derived: sum of 2 quarters · filed 2015-03-13 | $0.00 10-Q · filed 2015-03-13 | |
| 2013-10-31 | $0.00 10-Q · filed 2014-12-15 | $0.00 10-Q · filed 2014-12-15 | ||
| 2013-04-30 | $0.00 10-K/A · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |